Noticia

Se acaba de publicar el Programa de Trabajo (PT) extraordinario ad hoc sobre COVID19 del Clúster 1 Salud de Horizonte Europa en el contexto de la comunicación de la Comisión: HERA Incubator: Anticipando juntos la amenaza de las variantes de COVID-19 (https://ec.europa.eu/commission/presscorner/detail/es/ip_21_641). 

En breve se abrirá una convocatoria de Expresiones de Interés, que se publicará en breve en el Portal (Funding and Tenders Portal) y que incluirá 2 topics:   

• Support for the development of large scale, COVID19-related cohorts and networks beyond Europe’s borders, forging links with European initiatives as a global response to the pandemic;   
• Conduct of vaccine & therapeutic trials to boost prevention and further inform public health policy and clinical management  

Como documentación de referencia puede encontrar:   

• Introducción general de los Programas de Trabajo v1.0. https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-1-general-introduction_horizon-2021-2022_en.pdf
• Clúster 1 Salud - 90 M€. https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-4-health_horizon-2021-2022_en.pdf
• Anexos generales v1.0. https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-13-general-annexes_horizon-2021-2022_en.pdf

Adicionalmente, y en el mismo contexto, se publica el Programa de Trabajo (PT) extraordinario ad hoc sobre COVID19 del Programa de Infraestructuras de Horizonte Europa:

https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-3-research-infrastructures_horizon-2021-2022_en.pdf 

Convocatoria de Expresiones de Interés del Clúster de Salud:   

• Apertura: 13/abril   
• Cierre: 6/mayo/2021   
  • Publicación topics:   
  • HORIZON-HLTH-2021-CORONA-01-01 - Vaccines & therapeutic clinical trials to boost COVID-19 prevention and treatment 30 M€       
    • Horquilla financiación recomendada: Entre 3 y 10 M€       
    • The Commission expects to select at least one proposal on a vaccine and one on a therapeutic candidate for funding.   
  • HORIZON-HLTH-2021-CORONA-01-02 - Cohorts united against COVID-19 variants of concern 60 M€       
  • Horquilla financiación recomendada: Entre 7 y 10 M€   
• Condiciones especiales:   
  • Elegibilidad países: In particular, due to the urgency of this action and geographical relevance of this action and considering the Union’s interest to retain, in principle, relations with the countries associated to Horizon 2020, and other third countries in the process of association to Horizon Europe, legal entities established in Albania, Armenia, Bosnia and Herzegovina, Faroe Islands, Georgia, Iceland, Israel, Kosovo*, Moldova, Montenegro, Morocco, North Macedonia, Norway, Serbia, Switzerland, Tunisia, Turkey, Ukraine and United Kingdom are eligible for funding from the Union even if the Horizon Europe association agreement with the third country concerned does not apply at the time of signature of the grant agreement.   
  • Evaluación: In order to ensure a balanced portfolio covering responses to different aspects of the public health emergency under the specific actions above, and within each specific action, grants will be awarded to applications not only in order of ranking, but also to those projects that enhance the quality of the project portfolio through synergies between projects and avoidance of overlaps, provided that the applications attain all thresholds.   
  • Disposiciones de emergencia pública: beneficiaries must comply with the public emergency related provisions listed in the General Annexes of the Work Programme 2021 (part G - Legal and financial set-up of the grant agreements) and in the Model Grant Agreement concerning the project implementation under Intellectual Property Rights (IPR), background and results, access rights and rights of use (article 16 and Annex 5) for the duration of the pandemic; and under Communication, dissemination, open science and visibility (article 17 and Annex 5) during the entire duration of the action and for four years after the end of the action.   
  • Formulario para estudios en humanos: https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/essential-information-for-clinical-studies_horizon_en.pdf

El próximo 13 de abril se va a celebrar un webinario de convocatorias extraordinarias en COVID 19 de 10h a 11:30h. 

Los interesados pueden realizar el registro en: http://eu-isciii.es/formulario-webinar-convocatorias-extraordinarias-en-covid-19/

Si tiene interés en esta convocatoria extraordinaria en el marco de la pandemia, por favor, envía un correo electrónico ibipo@ffis.es indicando el interés y potencial para poder seguir en contacto con la Delegación española para Cluster 1. Health /Horizon Europe /Societal Challenges para informándole puntualmente. Dada la situación, los plazos van a ser muy breves.

Otra información publicada de interés NO correspondiente al Clúster de Salud:   

• Infraestructuras. Extraordinaria COVID19:       
  • FAIR and open data sharing in support to European preparedness for COVID-19 and other infectious diseases. TOPIC ID: HORIZON-INFRA-2021-EMERGENCY-01 12 M€. Cierre 6/mayo/2021.       
  • Research infrastructure services for rapid research responses to COVID-19 and other infectious disease epidemics. TOPIC ID: HORIZON-INFRA-2021-EMERGENCY-02 21 M€. Cierre 6/mayo/2021.
• EIC: Strategic Digital and Health Technologies. TOPIC ID: HORIZON-EIC-2021-ACCELERATORCHALLENGES-01-01 496,76 M€ (2021). Múltiples cierres a lo largo 2021.

Fuente: 

CDTI

Delegación Española para Cluster 1. Health

Horizon Europe. Societal Challenges